Just say no to drug reps - PowerPoint PPT Presentation

1 / 91
About This Presentation
Title:

Just say no to drug reps

Description:

Title: No Slide Title Author: Toshiba Preferred User Last modified by: wits Created Date: 7/24/2001 12:20:54 PM Document presentation format: On-screen Show – PowerPoint PPT presentation

Number of Views:227
Avg rating:3.0/5.0
Slides: 92
Provided by: ToshibaPr93
Category:
Tags: drug | graphs | misleading | reps

less

Transcript and Presenter's Notes

Title: Just say no to drug reps


1
Just say no to drug reps
2
The Physician-Pharmaceutical Industry Relationship
3
Are you drug company dependent?
If you answered yes to 2 or more of the above,
you may be drug company dependent.
4
Levels of Interactions
  • Clinicians
  • gifts
  • promotional information
  • Researchers
  • Professional societies medical journals
  • Continuing medical education (CME)

5
Case
  • It is a busy day in the office, but you have
    agreed to speak for a minute to a pharmaceutical
    representative who has stopped by to drop off
    some samples of a new quinolone antibiotic,
    called Ubiquinone. Knowing your interest in
    golf, he has brought you golf balls emblazoned
    with the letter U, and also invites you to a
    round of golf at the country club this weekend.
  • Would you accept the golf balls?
  • Would you accept the invitation?
  • (From Really difficult Problems in Medical
    Ethics)

6
Is it appropriate for a medical student to accept
any of the following gifts from a pharmaceutical
company?
  • small gifts (e.g. pens, writing pads, golf ball)
  • a free meal (e.g. lunch at a departmental journal
    club meeting or at a restaurant)
  • a textbook (worth R200)
  • a stethoscope (worth R500)
  • pharmaceutical samples (drug samples)
  • tickets to a Bafana Bafana game (worth R150)
  • sponsorship for travel and attendance at a
    conference (worth R3000)
  • free shares in the company (worth R1000)

7
Consider the following
  • Is there any potential for harm for the medical
    student?
  • What are the implications of accepting a gift
    from a pharmaceutical company?
  • Is there anthing wrong with getting something
    for nothing?
  • Why may pharmaceutical companies offer such
    freebies?
  • Should medical students response to the
    pharmaceutical industry regarding gifts differ
    from that of their seniors (qualified doctors)?
  • Would it be fair to prohibit all industry
    presence in medical schools and training
    hospitals and general practices where students
    are placed?

8
(No Transcript)
9
Attitudes and Practices
10
(No Transcript)
11
Are gifts from pharmaceutical companies ethically
problematic? A survey of physicians
  • Survey of 42 residents and 52 faculty at a
    university-based IM training program.
  • 21 item questionnaire. 4 point Likert scale.
  • 0 not problematic
  • 3 very problematic
  • 90 response rate (105/117 residents).
  • 93 of residents, 73 faculty responded.

Arch Intern Med. 20031632213-2218
12
Are gifts from pharmaceutical companies ethically
problematic? A survey of physicians
P.08
P.04
P.05
P.88
P.10
P.34
Arch Intern Med. 20031632213-2218
13
Of principles and pens attitudes and practices
of medicine housestaff toward pharmaceutical
promotions
  • Survey of 117 1st and 2nd year residents at a
    university-based IM training program.
  • Attitudes towards 9 types of promotion assessed.
  • 90 response rate (105/117 residents).

Am J Med 2001110551
14
Of principles and pens attitudes and practices
of medicine housestaff toward pharmaceutical
promotions
Am J Med 2001110551
15
Of principles and pens attitudes and practices
of medicine housestaff toward pharmaceutical
promotions Practices Among Residents Who
Consider Promotion Appropriate
Am J Med 2001110551
16
Of principles and pens attitudes and practices
of medicine housestaff toward pharmaceutical
promotions Practices Among Respondents Who
Consider Activity Inappropriate
Am J Med 2001110551
17
Of principles and pens attitudes and practices
of medicine housestaff toward pharmaceutical
promotions Perceived influence of
pharmaceutical reps on Prescribing Practices
You
Other Physicians
Plt.0001
Am J Med 2001110551
18
Pharmaceutical branding of Resident Physicians
  • Survey of 181 primary care residents 164 (91)
    responded.
  • First asked to complete survey, then asked to
    empty pockets of white coats.
  • 98 had eaten drug company-sponsored meal within
    the past year.
  • 97 of residents were carrying at least one item
    with pharmaceutical insignia.

JAMA 20012861024
19
Pharmaceutical Branding of Resident Physicians
JAMA 20012861024
20
Pharmaceutical Branding of Resident Physicians
JAMA 20012861024
21
(No Transcript)
22
Patient Attitudes
23
A comparison of physicians and patients
attitudes toward pharmaceutical industry gifts
  • Survey of physicians and patients at 2 tertiary
    care medical centers (1 military, 1 civilian).
  • 196 patients and 268 physicians completed survey.
  • 54 of patients were aware that pharmaceutical
    industry gave gifts to physicians.
  • Does your own doctor accept gifts? 27 yes, 20
    no, 53 unsure.

J Gen Int Med 199813151
24
A comparison of physicians and patients
attitudes toward pharmaceutical industry gifts

J Gen Int Med 199813151
Plt.004 for all except mug, p.24)
25
A comparison of physicians and patients
attitudes toward pharmaceutical industry gifts

J Gen Int Med 199813151
Plt0.0001 for all except trip, p0.0017
26
Professional Guidelines
27
American Medical AssociationCouncil on Ethical
Judicial Affairs
  • Any gifts accepted by physicians individually
    should primarily entail a benefit to patients and
    should not be of substantial value.
  • Subsidies from industry should not be accepted
    directly or indirectly to pay for the costs of
    travel, lodging, or personal expenses of the
    physicians who are attending the conferences and
    meetings . . .
  • No gifts should be accepted if there are strings
    attached.

JAMA 1991261501
28
American College of PhysiciansGuidelines on
Physician-Industry Relations
  • The acceptance of individual gifts, hospitality,
    trips, and subsidies of all types from industry
    by an individual physician is strongly
    discouraged.
  • The acceptance of even small gifts can affect
    clinical judgment and heighten the perception (as
    well as the reality) of a conflict of interest..
  • The dictates of professionalism require the
    physician to decline any industry gift or service
    that might be perceived to bias their judgment,
    regardless of whether a bias actually
    materializes.
  • Ideally, physicians should not accept any
    promotional gifts or amenities, whatever their
    value or utility, if they have the ability to
    cloud professional judgment and compromise
    patient care.
  • Annals of Internal Medicine 2002136396-402.

29
American College of PhysiciansGuidelines on
Physician-Industry Relations
  • Acceptable industry gifts
  • Inexpensive gifts for office use (pens and
    calendars).
  • Low cost gifts of an educational or patient-care
    nature (such as textbooks).
  • Modest refreshment.
  • Annals of Internal Medicine 2002136396-402.

30
PhRMA Code on interactions with healthcare
professionals
  • Items primarily for the benefit of patients may
    be offered to healthcare professionals if they
    are not of substantial value (100 or less).
  • Items of minimal value may be offered if they are
    primarily associated with a healthcare
    professionals practice.
  • Items intended for the personal benefit of
    healthcare professionals (CDs, tickets to a
    sporting event) should not be offered.

www.PhRMA.org, April 2002
31
(No Transcript)
32
PhRMA Code FAQs
  • Question
  • Under the Code, may golf balls and sports bags
    be provided if they bear a company or product
    name?
  • Answer
  • No.

www.PhRMA.org, April 2002
33
PhRMA Code FAQs
  • Question
  • Under the Code, may healthcare professionals be
    provided with gasoline for their cars if they are
    provided with product information at the same
    time?
  • Answer
  • No.

www.PhRMA.org, April 2002
34
PhRMA Code FAQs
  • Question
  • Under the Code, may items such as stethoscopes
    be offered to healthcare professionals?
  • Answer
  • Yes

www.PhRMA.org, April 2002
35
That stuff doesnt influence me at all. I dont
even know what drug is on my pen. I just go for
the food. --Fill in your name here?
36
Pharmaceutical industry Spending on Promotion
37
Promotional spending on prescription drugs,
l996-2002
Source NIHCM, 2001
38
Promotional spending on prescription drugs, 2002
Total spending 21 billion
Source IMS Health
39
Direct to consumer advertising on prescription
drugs, l996-2000
Source NIHCM, 2001
40
Direct to consumer advertising spending in the
U.S., 2000
Source NIHCM, 2001
41
Comparison of median revenue dedicated to RD,
profits, and marketing/administration, Fortune
500 drug companies, 2000 (n11)
Source Public Citizen, 2001
42
Main task of drug company employees, 2000
Source PhRMA Industry Profile 2000 percentages
calculated by Sager and Socolar
43
Drug company jobs in marketing and research,
1995-2000
Jobs
Source PhRMA Industry Profile 2000 percentages
calculated by Sager and Socolar
44
Profitability of drug industry, l993-2000
2.8
  • Source Public Citizen update of Stephen W.
    Schondelmeyer calculation, Competition and
    Pricing Issues in the Pharmaceutical Market,
    PRIME Institute, University of Minnesota based on
    data found in Fortune magazine, 1958 to 1999
    Fortune magazine, April 2000, Fortune 500
    (www.fortune.com).

45
Fortune 500 drug company profitability compared
to all other Fortune 500 companies, 2000
Source Public Citizen, 2001
46
(No Transcript)
47
Sources of increased drug expenditures, 2000-2001
37
39
24
Total increase 22.5 billion
Source NIHCM, 2002
48
Gifts are just a form of promotion or
advertising, and advertising is a part of our
society, like it or not.
49
Gifts
  • Cost money (like other advertising).
  • Influence behavior (like other advertising).
  • Create obligation, need to reciprocate (unlike
    advertising). Conflict of interest
  • Create sense of entitlement (unlike advertising).
  • Erode professional values demean profession
    (probably unlike advertising).

50
Conflict of interest
  • Set of conditions in which judgement concerning a
    primary interest tends to be unduly influenced by
    a secondary interest.

NEJM 1993329573-6
51
Conflict of interest?
  • I have never been bought, I cannot be bought. I
    am an icon, and I have a reputation for honesty
    and integrity, and let the chips fall where they
    may. It is true that there are people in my
    situation who could not receive a million-dollar
    grant and stay objective. But I do.

52
That stuff doesnt influence me at all. I dont
even know what drug is on my pen. I just go for
the food. --Fill in your name here?
53
Should doctors be held to different (higher)
standards?
54
The physician-patient relationship is a fiduciary
relationship.
55
Characteristics of a Fiduciary
  • Has specialized knowledge or expertise
  • Holds the trust of others
  • Held to high standards of conduct
  • Avoids conflicts of interest
  • Is accountable or obligated (ethically and
    legally)

56
That stuff doesnt influence me at all. I dont
even know what drug is on my pen. I just go for
the food. --Fill in your name here?
57
Influence
58
The Effects of Pharmaceutical Firm Enticements on
Physician Prescribing Patterns
  • Pharmacy records reviewed 22 months before and 17
    months after two pharmaceutical company-sponsored
    symposia on two medications
  • Drug A New intravenous antibiotic
  • Promotion All-expenses-paid trip to luxurious
    resort on West Coast (n10 travelling MDs)
  • Drug B New intravenous Cardiac drug
  • Promotion All-expense-paid trip to island resort
    in the Caribbean (n10 travelling MDs)

Chest 1992102270
59
The Effects of Pharmaceutical Firm Enticements on
Physician Prescribing Patterns
Chest 1992102270
60
Physicians' Behavior and their Interaction with
Drug Companies
  • Case-control study at a University Hospital
  • Cases 40 physicians who had requested formulary
    additions.
  • Controls 80 physicians who had made no such
    requests.
  • Information regarding interaction with drug
    companies obtained by survey instrument.

JAMA 1994271684
61
Physicians' Behavior and their Interaction with
Drug Companies
  • Physicians who had requested formulary changes
    were more likely to have accepted money from drug
    companies to attend or speak at symposia.
  • (OR5.1, 95CI, 2.0 - 13.2)
  • Physicians were more likely to have requested
    additions of drugs made by companies with whose
    reps they had met (OR4.9, 95CI, 3.2 - 7.4).

JAMA 1994271684
62
Scientific versus commercial sources of influence
  • Telephone questionnaire of 85 randomly selected
    internists in Boston area
  • Questioned about two classes of drugs
  • Propoxyphene analgesics
  • Cerebral and peripheral vasodilators.

Am J Med 19822734
63
Scientific versus Commercial Sources of Influence
Am J Med 19822734
64
Scientific versus Commercial Sources of Influence
Am J Med 19822734
65
Scientific versus Commercial Sources of Influence
on the Prescribing behavior of Physicians
  • Were physicians who believed these drugs to be
    effective more likely to rely on commercial than
    scientific sources?
  • Vasodilators Yes (p0.006)
  • Propoxyphene No

Am J Med 19822734
66
A Physician Survey of the Effect of Drug Sample
Availability on Physicians Behavior
  • Setting University-based clinics at an academic
    medical center.
  • Participants 131 of 154 general medicine and
    family physicians.
  • 79 residents, 52 attendings.
  • Questionnaire.
  • Three hypothetical clinical scenarios Patient
    with uncomplicated urinary tract infection,
    hypertension, depression.

J Gen Int Med 200015478
67
A physician survey of the effect of drug sample
availability on physicians behavior
  • HTN scenario
  • 92 said they would prescribe a diuretic or
    b-blocker as initial therapy.
  • When samples were made available, 32 of the 35
    physicians who said they would give a drug sample
    selected a drug that differed from their
    preferred choice.

J Gen Int Med 200015478
68
A physician survey of the effect of drug sample
availability on physicians behavior
  • HTN follow-up scenario
  • Patient now has health insurance, blood
    pressure controlled on drug sample
  • 69 said they would write a prescription for the
    sampled medication rather than switch therapy.
  • 88 of sample users would have written a
    prescription for a drug that differed from their
    preferred choice.

J Gen Int Med 200015478
69
Physicians, Pharmaceutical Sales Representatives,
and the Cost of Prescribing
  • Questionnaire on attitudes toward and use of
    information provided by pharmaceutical
    representatives.
  • Mailed to all primary care adult medicine
    practitioners in Kentucky (n1603)
  • Main outcome measure Relative cost of
    prescribing, based on responses to treatment
    choices for clinical scenarios.
  • 36 response 446 questionnaires suitable for
    analysis.

Arch of Fam Med 19965201
70
Physicians, Pharmaceutical Sales Representatives,
and the Cost of Prescribing

Arch of Fam Med 19965237
71
Physicians, Pharmaceutical Sales Representatives,
and the Cost of Prescribing
  • 3 case scenarios acute bronchitis, mild HTN,
    and uncomplicated UTI.
  • Positive correlation found between physician
    cost of prescribing and
  • perceived credibility of information provided by
    pharmaceutical reps (plt.01).
  • Frequency of use of reps as information source
    (plt.001)
  • Physician age, years since graduation, hours
    worked per week was not correlated with cost of
    prescribing

Arch of Fam Med 19965237
72
Bias in promotional materials
73
Pharmaceutical Advertisements in Leading Medical
Journals Experts Assessments
  • Peer review of all ads from 10 journals during
    January, 1990.
  • 109 advertisements were analyzed by 113
    experienced physician peer reviewers and 54
    clinical pharmacists.
  • 71 of reviewers had received money from the drug
    industry within the past 2 years 53 had
    received more than 5000.

Ann Int Med 1992116912
74
Pharmaceutical Advertisements in Leading Medical
Journals Experts Assessments
  • FDA regulations specify that ads are false,
    lacking in fair balance, or otherwise misleading
    if
  • They make claims about relative safety and
    efficacy or about the populations in which the
    drug is useful that are not supported by the
    current literature.
  • Use literature or references inappropriately to
    support claims in the advertisement.
  • Use statistics erroneously.
  • Use headlines, sub-headlines, or pictorial or
    other graphic material in way that is misleading.

Ann Int Med 1992116912
75
Pharmaceutical Advertisements in Leading Medical
Journals Experts Assessments
Ann Int Med 1992116912
76
The Quantity and Quality of Scientific Graphs in
Pharmaceutical Advertisements
  • Review of all pharmaceutical ads in from 10
    leading American journals in 1999.
  • 498 unique advertisements (3,185 total).
  • 74 unique graphs

JGIM 200318294-297
77
The Quantity and Quality of Scientific Graphs in
Pharmaceutical Advertisements
  • 36 of graphs contained numeric distortion.
  • 66 of graphs contained chart junk.
  • 54 reported intermediate outcomes.

JGIM 200318294-297
78
Logical Fallacies in Pharmaceutical
PromotionSample Ads available on request from
No Free Lunch
JGIM, 1994 9563
79
Logical Fallacies in Pharmaceutical Promotion
  • Argumentum ad populum
  • Appeal to popularity

80
Logical Fallacies in Pharmaceutical Promotion
  • Argumentum ad verecundiam
  • Appeal to authority

81
Logical Fallacies in Pharmaceutical Promotion
  • Argumentum ad celebritam
  • Appeal to celebrity

82
(No Transcript)
83
(No Transcript)
84
Logical Fallacies in Pharmaceutical Promotion
  • Fallacy of ignoratio elenchi
  • (or fallacy of irrelevant conclusions,
  • or fallacy of ignoring the issue
  • or the non-sequitur)

85
Logical Fallacies in Pharmaceutical Promotion
  • Appeal to emotion

86
Dealing with conflicts of interest
  • Prohibition
  • Divestiture
  • Abstention
  • Mediation
  • Disclosure

NEJM 1993329573
87
Epilogue Do doctors need drug reps?
  • Medical Letter (www.medicalletter.com)
  • Therapeutics Initiative (Canada)
  • (www.ti.ubc.ca)
  • Drug and Therapeutics Bulletin (UK)
  • (www.which.net/health/dtb)
  • Prescrire.org (France)
  • etc.

88
Conclusion
  • The patient-physician relationship is a fiduciary
    relationship.
  • Fiduciaries have an obligation to avoid conflicts
    of interest.
  • Gifts from the pharmaceutical industry, whether
    large or small, create conflicts of interest.
  • Physicians should not accept any gifts from the
    pharmaceutical industry.

89
Just say no to drug reps
90
(No Transcript)
91
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com